NextCure, Inc. (NXTC) Operating income 2018–2025
NextCure, Inc. (NXTC) annual operating income history from SEC filings — each fiscal year as reported.
-$57.6MFY2025 · since FY2018: -$23.2M → -$57.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$57.6M | +3.6% |
| FY2024 | -$59.7M | +11.7% |
| FY2023 | -$67.6M | +10.9% |
| FY2022 | -$75.9M | -7.3% |
| FY2021 | -$70.8M | -71.7% |
| FY2020 | -$41.2M | -10.0% |
| FY2019 | -$37.5M | -61.6% |
| FY2018 | -$23.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice